Literature DB >> 30721530

In times of tobacco-free nicotine consumption: The influence of nicotine on vascular calcification.

Milen Babic1, Mirjam Schuchardt1, Markus Tölle1, Markus van der Giet1.   

Abstract

BACKGROUND: Smoking remains the most important avoidable cause of global mortality. Even though the number of cigarette smokers declines in first world countries, the uses of alternative nicotine delivery products increase and may even surpass the sells of cigarettes. In this light, the explicit role of nicotine in the development of cardiovascular diseases should be elucidated.
OBJECTIVES: This narrative review attempts to connect current literature about possible effects of nicotine on the environment of the vasculature to the pathogenesis of vascular calcification, focusing on the tunica media of the vessel wall.
METHODS: For this review, papers found on Pubmed and Medline until December 2018 by searching for the keywords nicotine, vascular calcification, oxidative stress, osteoblastic transdifferentiation and matrix degradation were considered.
RESULTS: Nicotine creates an environment that probably facilitates and maybe even induces osteogenic transdifferentiation of VSMC by inflammation, endothelial dysfunction and reactive oxygen species. This process is believed to be a key event in calcification of the tunica media of the vessel wall. Furthermore, nicotine could lead to the formation of nucleation sites for hydroxyapatite by facilitating matrix vesicles and extracellular matrix degradation.
CONCLUSIONS: There is a growing body of evidence implicating that nicotine alone could impair vascular function and lead to vascular calcification. Further research is necessary to elucidate the explicit influence of nicotine on arteriosclerosis.
© 2019 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  arteriosclerosis; calcification; e-cigarette; nicotine; oxidative stress; smoking; stiffness

Mesh:

Substances:

Year:  2019        PMID: 30721530     DOI: 10.1111/eci.13077

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers.

Authors:  Kevin P Jensen; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Psychopharmacology (Berl)       Date:  2020-01-29       Impact factor: 4.530

2.  Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.

Authors:  Joao P De Aquino; R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; Tore Eid; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

Review 3.  What are the respiratory effects of e-cigarettes?

Authors:  Jeffrey E Gotts; Sven-Eric Jordt; Rob McConnell; Robert Tarran
Journal:  BMJ       Date:  2019-09-30

Review 4.  The Biological Effects of Smoking on the Formation and Rupture of Intracranial Aneurysms: A Systematic Review and Meta-Analysis.

Authors:  Hanbin Wang; Luxuan Wang; Jiyue Wang; Lijian Zhang; Chunhui Li
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

5.  Nicotine exacerbates atherosclerosis through a macrophage-mediated endothelial injury pathway.

Authors:  ChengYu Mao; DongJiu Li; En Zhou; JunFeng Zhang; ChangQian Wang; Chao Xue
Journal:  Aging (Albany NY)       Date:  2021-02-24       Impact factor: 5.682

6.  Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells.

Authors:  Ploingarm Petsophonsakul; Mathias Burgmaier; Brecht Willems; Sylvia Heeneman; Nadina Stadler; Felix Gremse; Sebastian Reith; Kathrin Burgmaier; Florian Kahles; Nikolaus Marx; Ehsan Natour; Elham Bidar; Michael Jacobs; Barend Mees; Chris Reutelingsperger; Malgorzata Furmanik; Leon Schurgers
Journal:  Cardiovasc Res       Date:  2022-07-20       Impact factor: 13.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.